The Muscular Dystrophy Association has awarded 40 research grants totaling $13.7 million to advance the understanding of disease processes and uncover new strategies for treatments and cures of muscular dystrophy and the more than 40 other diseases in the Association's program.
The new grants were recommended by MDA's Scientific and Medical Advisory Committees and approved by MDA's Board of Directors at its July 2011 meeting.
If you’ve just learned that you or a loved one has a metabolic muscle disorder, you’re probably both relieved and concerned. That’s how I felt when I learned at age 27 that I have phosphorylase deficiency, or McArdle disease.
A clinical trial is a test in humans of an experimental medication or therapy. Clinical trials are experiments, not treatments, and participation requires careful consideration.
Although it's possible to benefit from participating in a clinical trial, it's also possible that no benefit — or even harm — may occur. Keep your MDA clinic doctor informed about any clinical trial participation. (Note that MDA has no ability to influence who is chosen to participate in a clinical trial.)
MDA-funded scientists are pursuing a number of promising leads in their quest to understand the causes of the metabolic diseases of muscle.
To date, scientists have isolated all of the genes involved in the metabolic myopathies described here, and their genetic codes have been unraveled, offering insight into how particular gene defects lead to disease. In addition, isolation of genes has allowed researchers to begin experiments with gene therapy, a potential cure for some metabolic diseases.